NIDAN — Nidan Laboratories and Healthcare Income Statement
0.000.00%
Last trade - 00:00
- IN₹456.62m
- IN₹486.40m
- IN₹242.66m
- 58
- 67
- 36
- 56
2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 210 | 222 | 204 | 297 | 243 |
Cost of Revenue | |||||
Gross Profit | — | — | 182 | 266 | 232 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 207 | 215 | 72.2 | 92.8 | 61.3 |
Operating Profit | 2.23 | 7.15 | 132 | 204 | 181 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.23 | 7.15 | 33 | 45.2 | 48.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.23 | 7.15 | 23 | 26.6 | 35.4 |
Net Income Before Extraordinary Items | |||||
Net Income | 2.23 | 7.15 | 23 | 26.6 | 35.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.23 | 7.15 | 23 | 26.6 | 35.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.161 | 0.514 | 1.66 | 2.17 | 2.4 |
Dividends per Share |